Caladium Seguinum-Injeel Forte Liq (4d,12d,30d,200d/1.1ml) 4 D / 1.1 mL Liquid is a Health Canada–registered human drug (DIN 02070472) held by Biologische Heilmittel Heel GmbH, containing Caladium Seguinum. Health Canada lists its status as Cancelled Post Market (status date 15 Jan 1997). Nexara Health has matched 11 registrations of Caladium Seguinum across 2 other regulated markets.
Health Canada registration
| DIN | 02070472 |
|---|---|
| Brand name | Caladium Seguinum-Injeel Forte Liq (4d,12d,30d,200d/1.1ml) |
| Active ingredient | Caladium Seguinum |
| Strength | 4 D / 1.1 mL |
| Dosage form | Liquid |
| Route | Oral |
| Company | Biologische Heilmittel Heel GmbH |
| Status | Cancelled Post Market — 15 Jan 1997 |
| Class | Human |
| ATC | |
| AHFS | 92:02.00* ; See footnote |
| Regulator record | Health Canada DPD entry · Product monograph |
Caladium Seguinum registered in other markets
11 registrations of the same molecule in 2 national registries outside Canada (first 10 shown, exact strength and form first). Each row is taken from the regulator's own published list; status is shown as the registry reports it.
| Country | Product | Marketing authorisation holder | Strength | Form | Status | Registry |
|---|---|---|---|---|---|---|
| Netherlands | Caladium seguinum | BOIRON (Messimy) | 4 DH t/m 60 DH#2 CH t/m 200 CH#6 K t/m 100.000 K#1 LM t/m 30 LM | Uitsluitend apotheek of drogist | EU national register | |
| Netherlands | Caladium seguinum | BOIRON (Messimy) | 4 DH t/m 60 DH#2 CH t/m 200 CH#6 K t/m 100.000 K#1 LM t/m 30 LM | Globuli | Uitsluitend apotheek of drogist | EU national register |
| United States | Caladium Seguinum | Hahnemann Laboratories, INC. | Pellet | listed | FDA NDC | |
| United States | Caladium Seguinum | Hahnemann Laboratories, INC. | Pellet | listed | FDA NDC | |
| United States | Caladium Seguinum | Hahnemann Laboratories, INC. | Pellet | listed | FDA NDC | |
| United States | Caladium Seguinum | Hahnemann Laboratories, INC. | Pellet | listed | FDA NDC | |
| United States | Caladium Seguinum | Hahnemann Laboratories, INC. | Pellet | listed | FDA NDC | |
| United States | Caladium Seguinum | Hahnemann Laboratories, INC. | Pellet | listed | FDA NDC | |
| United States | Caladium Seguinum | Hahnemann Laboratories, INC. | Pellet | listed | FDA NDC | |
| United States | Caladium Seguinum | Hahnemann Laboratories, INC. | Pellet | listed | FDA NDC |
See every manufacturer of Caladium Seguinum worldwide →
Sourcing through Nexara Health
Nexara Health is a Health Canada–licensed wholesaler (DEL #3-002896) in Winnipeg. This DIN is not currently marketed in Canada. The registrations above show which regulated markets hold an equivalent presentation that can be sourced for clinical comparator use or on a named-patient basis under Health Canada's Special Access Programme. Request a quote or read how named-patient and foreign-pack supply works in Canada.
Frequently asked questions
Is Caladium Seguinum-Injeel Forte Liq (4d,12d,30d,200d/1.1ml) (DIN 02070472) marketed in Canada?
No. Health Canada lists DIN 02070472 as Cancelled Post Market as of 15 Jan 1997.
Who holds the Canadian licence for this product?
Biologische Heilmittel Heel GmbH is the company of record in the Health Canada Drug Product Database.
Is Caladium Seguinum registered outside Canada?
Yes — Nexara Health has matched 11 registrations in 2 other markets (see the table above).
Where does this data come from?
Health Canada Drug Product Database (DPD), DIN 02070472, status date 1997-01-15; national medicine registries: EU national register, FDA NDC. Nexara Health re-checks these sources weekly and shows the last verification date at the top of the page.
Source: Health Canada Drug Product Database (DPD), DIN 02070472, status date 1997-01-15; national medicine registries: EU national register, FDA NDC.
Health Canada Drug Product Database (DPD), DIN 02070472, status date 1997-01-15; national medicine registries: EU national register, FDA NDC. Last reviewed 2026-09-16. Nexara Health is a licensed wholesaler and supplies licensed entities only; consumer orders are routed to a partner pharmacy.